Alan H Mutnick - JoVE Visualize

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

The Journal of Antimicrobial Chemotherapy|January 9, 2004

Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America (1999-2001)Alan H Mutnick, Paul R Rhomberg, Helio S Sader, et al.

Diagnostic Microbiology and Infectious Disease|August 2, 2002

Geographic variations in garenoxacin (BMS284756) activity tested against pathogens associated with skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (2000)Jeffrey T Kirby, Alan H Mutnick, Ronald N Jones, et al.

Diagnostic Microbiology and Infectious Disease|June 29, 2002

Antimicrobial susceptibility patterns of beta-hemolytic and viridans group streptococci: report from the SENTRY Antimicrobial Surveillance Program (1997-2000)Kelley A Gordon, Mondell L Beach, Douglas J Biedenbach, et al.

Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

The Journal of Antimicrobial Chemotherapy|January 9, 2004

Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America (1999-2001)Alan H Mutnick, Paul R Rhomberg, Helio S Sader, et al.

Diagnostic Microbiology and Infectious Disease|August 2, 2002

Geographic variations in garenoxacin (BMS284756) activity tested against pathogens associated with skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (2000)Jeffrey T Kirby, Alan H Mutnick, Ronald N Jones, et al.

Diagnostic Microbiology and Infectious Disease|June 29, 2002

Antimicrobial susceptibility patterns of beta-hemolytic and viridans group streptococci: report from the SENTRY Antimicrobial Surveillance Program (1997-2000)Kelley A Gordon, Mondell L Beach, Douglas J Biedenbach, et al.

Pageof 2